US$3,500.00
Feb 2010
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
GBI Research, the leading business intelligence provider, has released its latest research “Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma”, which provides insights into the unmet needs in the pharmaceutical and healthcare market and potential segments where RNA therapies can prove to be useful. This pharma report also delves deep into the market potential that RNA therapies hold in the future. Further, it provides insights into the R&D pipeline and the promising drugs. The study elucidates the current competitive landscape of the RNA therapeutics market. Finally, the report deals with key trend analysis on mergers and acquisitions, and licensing agreements involving RNA therapies.
Order Now |
More Information |
Tell-a-Friend
US$4,650.00
Dec 2009
Global RNAi Technology Market (2009 - 2014)
RNAi (Ribonucleic Acid Interference) a system in live cells to keep a check on the active genes is the next promising technology in the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery and therapeutics.
Order Now |
More Information |
Tell-a-Friend
US$3,835.00
Sep 2008
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
‘The Future of RNAi Therapeutics: Drug pipelines and prospects’ is a report published by Business Insights that provides an in-depth assessment of recent progress and future opportunities for RNAi players in major therapeutic areas including infectious diseases, cancer, inflammation/immune dysfunction, CNS disorders and cardiology/metabolism. The latest trends in RNAi therapeutics are examined, focusing on the main areas of clinical need, general/proprietary technologies and company pipelines, and the activities and strategies of 37 RNAi-based developers are profiled. This report also provides forecasts for market growth to 2012 across major RNAi market segments.
Order Now |
More Information |
Tell-a-Friend
|
